A Novel Classification Method using Effective Neural Network and Quantitative Magnetization Transfer Imaging of Brain White Matter in Relapsing Remitting Multiple Sclerosis

Authors

Abstract:

Background: Quantitative Magnetization Transfer Imaging (QMTI) is often used to quantify the myelin content in multiple sclerosis (MS) lesions and normal appearing brain tissues. Also, automated classifiers such as artificial neural networks (ANNs) can significantly improve the identification and classification processes of MS clinical datasets.Objective: We classified patients with relapsing-remitting multiple sclerosis (RRMS) from healthy subjects using QMTI and T1 longitudinal relaxation time data of brain white matter and the performance of three ANN-based classifiers have been investigated.   Materials and Methods: Conventional magnetic resonance imaging (MRI) and quantitative magnetization transfer scans were obtained from RRMS patients (n=30) and age-matched healthy subjects (n=30). After image pre-processing and brain tissue segmentation, QMTI parameters including magnetization transfer ratio (MTR), magnetization transfer rate (Ksat), T1 relaxation time under MT saturation pulse (T1sat) and T1 longitudinal relaxation time were calculated as parametric maps. Three ANN algorithms, including multilayer perceptron (MLP), radial basis function (RBF) and ensemble neural network based on Akaike information criterion (ENN-AIC) input features were extracted in the form of QMTI and T1 mean values. The ANNs quantitative performance is measured by the standard evaluation of confusion matrix criteria.Results: The results indicate that ENN-AIC-based classification method has achieved 90% accuracy, 92% sensitivity and 86% precision compared to other ANN classification models such as RBF and MLP. NPV, FPR and FDR values of the proposed ENN-AIC model were found to be 0.933, 0.125 and 0.133, respectively. A graphical representation of how to track actual data by the predictive values derived from each of the three algorithms, was also presented. It has been demonstrated that ENN-AIC as an effective neural network improves the quality of classification results compared to MLP and RBF.Conclusion: The efficiency and robustness of ENN classifier will greatly enhance with the use of AIC-based combination weights assignment. In addition, this research  provides a new direction to classify a large amount of quantitative MRI data that can help the physician in a correct MS diagnosis.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Pathological Assessment of Brain White Matter in Relapsing-Remitting MS Patients using Quantitative Magnetization Transfer Imaging

Introduction: Multiple sclerosis (MS) is characterized by lesions in the white matter (WM) of the central nervous system. Magnetic resonance imaging is the most specific and sensitive method for diagnosis of multiple sclerosis. However, the ability of conventional MRI to show histopathologic heterogeneity of MS lesions is insufficient. Quantitative magnetization transfer imaging (qMTI) is a rel...

full text

The Assessment of Structural Changes in MS Plaques and Normal Appearing White Matter Using Quantitative Magnetization Transfer Imaging (MTI)

Introduction: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS), affecting mostly young people at a mean age of 30 years. Magnetic resonance imaging (MRI) is one of the most specific and sensitive methods in diagnosing and detecting the evolution of multiple sclerosis disease. But it does not have the ability to differentiate between distinct histopathologic...

full text

Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter.

PURPOSE To determine the fractional brain tissue volume changes in the gray matter and white matter of patients with relapsing-remitting multiple sclerosis (MS) and to correlate these measurements with clinical disability and total lesion load. MATERIALS AND METHODS Thirty patients with relapsing-remitting MS and 25 healthy control subjects underwent magnetic resonance imaging. Fractional bra...

full text

Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis.

BACKGROUND AND PURPOSE Gray matter may be affected by multiple sclerosis (MS), a white matter disease. Magnetization transfer ratio (MTR) is a sensitive and quantitative marker for structural abnormalities, and has been used frequently in the imaging of MS. In this study, we evaluated the amount of MTR of gray matter among patients with relapsing-remitting MS and healthy control subjects as wel...

full text

Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.

BACKGROUND Magnetization transfer (MT) magnetic resonance imaging (MRI) can provide in vivo quantitative estimates of microscopic tissue damage in normal-appearing white matter (NAWM) and gray matter (GM) from patients with multiple sclerosis (MS). OBJECTIVE To determine whether a one-time MT MRI can provide markers of short-term disease evolution in patients with relapsing-remitting MS. DE...

full text

Normal-appearing White Matter Quantitative Magnetization Transfer Imaging correlates with Disability in Multiple Sclerosis

Introduction Multiple sclerosis (MS) is an inflammatory disease of the central nervous system, whose neuroradiological hallmark are multifocal white matter (WM) lesions. Several pathological and MRI studies based on quantitative techniques have clearly demonstrated that diffuse abnormalities are present in the normal appearing WM (NAWM) and in lesions, and that they partially explain symptom se...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 8  issue 4

pages  -

publication date 2018-12-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023